Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Program Trains Patient Research Advocates to be STARS

… Program Trains Patient Research Advocates to be STARS … Lauren Evoy Davis …

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs

… Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs … Leah Lawrence …

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

… Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors …

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

… weight gain represents a promising avenue for further research. The successful combination of a GLP-1-RA and a TKI … treatment strategy. A new prospective cohort study by our research group specifically addresses this issue in patients …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …